Dr. Gary Gilliland
Dr. Gary Gilliland is president and director of Seattle’s Fred Hutchinson Cancer Research Center. He is an expert in cancer genetics and precision medicine who has devoted his life to finding better treatments and cures for diseases.
Resources for more information
Biologist is ninth Hutch researcher to join one of the nation's oldest learned societies
April 18, 2018 in Hutch News
2018 class of fellows recognized for significant contributions to cancer research
April 3, 2018 in Hutch News
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
March 30, 2018 in Hutch News
Fred Hutch leaders helped shape recommendations that put patients first, promoting value, affordability, innovation
March 12, 2018 in Hutch News
Texas Rangers pitcher becomes 53rd recipient of coveted baseball honor
Jan. 25, 2018 in Hutch News
Celebrating faculty and staff achievements
Dec. 14, 2017 in Hutch News
Celebrating faculty and staff achievements
Dec. 7, 2017 in Hutch News
Dr. Geoffrey Hill will help integrate bone marrow transplantation with emerging cancer immunotherapies
Dec. 7, 2017 in Hutch News
Patient stories at forefront of evening featuring food, drink, music — and a surprise celebrity
Dec. 5, 2017 in Hutch News
Her one-year term will be followed by successive terms as president-elect and president
Nov. 1, 2017 in Hutch News
FOR THE MEDIA
Hutch Team
For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.
